Moreover, we found that the tumor-intrinsic PD-L1 signaling could be activated by PD-1, suggesting that PD-L1 functions as a receptor and PD-L1 antibodies may also alternate PD-L1 tumor-intrinsic functions. The gene discussed is CD274; the disease is neoplasm.